2.650USD-0.38%Mkt Cap: 339.06M USDP/E: —Last update: 2026-05-26
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced w…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap339.06M USD
Enterprise Value458.55M USD
Revenue (TTM)514.70M USD
Gross Profit425.51M USD
Net Income (TTM)37.03M USD
Revenue/Share4.049 USD
Last Price2.650 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees854
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS68621F1021
Valuation
P/E (Trailing)—
P/E (Forward)-11.57
PEG—
EV/EBITDA11.21
EV/Revenue0.89
P/S0.66
P/B1.13
EPS (TTM)-0.12
EPS (Forward)-0.23
52W Range
2.04012% of range7.077
52W High7.077 USD
52W Low2.040 USD
Profitability
Gross Margin75.57%
Oper. Margin-174.69%
EBITDA Margin7.95%
Profit Margin6.58%
ROE8.53%
ROA6.19%
Growth
Revenue Growth-57.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.31M USD
CapEx (TTM)14.15M USD
FCF Margin5.07%
FCF Yield7.70%
Net Debt-20.52M USD
Net Debt/EBITDA-0.50
Balance Sheet
Debt/Equity0.19
Current Ratio3.53
Quick Ratio2.74
Book Value/Sh2.364 USD
Cash/Share0.7100 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.128.67M
Float57.38M
Insiders47.46%
Institutions50.03%
Short Interest
Short Ratio7.5d
Short % Float19.38%
Short % Out.12.32%
Shares Short15.86M
Short (prev mo.)12.79M
Technical
SMA 502.443 (+8.5%)
SMA 2003.970 (-33.3%)
Beta1.31
S&P 52W Chg28.31%
Avg Vol (30d)1.38M
Avg Vol (10d)1.73M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—